CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Nature Reviews Drug Discovery
High ImpactOriginal article

Orexin receptor agonist secures landmark narcolepsy approval

RegulatoryapprovedPositive
AI Analysis

Summary

An orexin receptor agonist has received landmark FDA approval for narcolepsy treatment. The approval represents a significant regulatory milestone for the drug class in this indication.

Importance:8/10
Sentiment:
0.80
FDA approvalnarcolepsyorexin receptor agonistlandmark

Read the original article

Published by Nature Reviews Drug Discovery on August 10, 2026 12:00 AM

Read Original